✦ LIBER ✦

Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer

✍ Scribed by J.F.R. Robertson; A. Howell; D.J. De Friend; R.W. Blarney; P. Walton

Book ID: 114316998
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 393 KB
Volume: 6
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(97)90571-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modulatory effect of tamoxifen and ICI 1

Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells

✍ Rosa De Vincenzo; Giovanni Scambia; Pierluigi Benedetti Panici; Andrea Fattoross 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 865 KB

In this study the ability of the new pure anti-estrogen IcI 182,780 to modulate the cytotoxic action of adriamycin (ADR) on parental and ADR-resistant MCF-7 (MCF-7 ADRr) human breast-cancer cells was investigated and compared with that of tamoxifen (TAM). TAM enhanced ADR cytotoxicity in MCF-7 ADRr

Sensitization to doxorubicin resistance

Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate

✍ Lawrence Panasci; Bertrand J. Jean-Claude; Daniela Vosilescu; Amir Mustafa; Sori 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 848 KB

Anti-proliferative and anti-estrogenic e

Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells

✍ Peter Coopman; Marcel Garcia; Nils Brünner; Danielle Derocq; Robert Clarke; Henr 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 868 KB

The effects of the anti-estrogens 4-hydroxytamoxifen (OHTam), ICI 164,384 and ICI 182,780 were tested on the MCF-7/LCC2 breast-carcinoma cell line, which grows significantly in the presence of OHTam and serves as a model for studying anti-estrogen resistance of estrogen-receptor-positive breast canc

Overcoming resistance to fulvestrant (IC

Overcoming resistance to fulvestrant (ICI182,780) by Downregulating the c-ABL Proto-Oncogene in breast cancer

✍ Huajun Zhao; Yuan-Hung Lo; Ling Yu; Shao-Chun Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB

## Abstract Inhibiting estrogen receptor (ER) function with specific estrogen receptor modulators (SERM) can achieve a primary response in cancer patients; however, intrinsic or subsequently acquired resistance to the therapy remains a major obstacle in treatment. The pure anti‐estrogen fulvestrant

Changes in oestrogen receptor-α and -β d

Changes in oestrogen receptor-α and -β during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells

✍ L.E. Shaw; A.J. Sadler; D. Pugazhendhi; P.D. Darbre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Induction of insulin‐like growth factor

Induction of insulin‐like growth factor binding protein expression by ICI 182,780 in a tamoxifen‐resistant human breast cancer cell line

✍ John P. Parisot; Kerri S. Leeding; Xiu F. Hu; Mario DeLuise; John R. Zalcberg; L 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 167 KB